PDGFRB and breast carcinoma: Moreover, this data is in direct contrast to pericyte trends identified in brain metastases of breast cancer, which demonstrated a loss of PDGFR-β-positive pericytes, a loss in CD13-positive pericytes, and increase in desmin-positive pericytes [27].